Ascendia Pharmaceutical Solutions will participate in the Contract Pharma Conference, taking place September 24–25, 2026, at the Hyatt Regency in New Brunswick, New Jersey. The annual event brings together pharmaceutical and biotechnology outsourcing leaders focused on drug development, formulation innovation, clinical manufacturing, commercial scale-up, and supply chain strategy.
During the conference, Ascendia Pharmaceutical Solutions will meet with pharmaceutical and biotech companies seeking integrated CDMO support across formulation development, analytical services, clinical manufacturing, technology transfer, and commercial manufacturing preparation.
Conference schedules fill quickly. Contract Pharma Conference attendees are encouraged to schedule meetings with Ascendia Pharmaceutical Solutions before the event to secure dedicated time with the company’s executive leadership and technical experts.
Pre-scheduled meetings at table 141 provide opportunities for focused discussions around formulation strategy, manufacturing planning, CMC development priorities, regulatory considerations, and commercialization timelines. These conversations are designed to help sponsors evaluate development pathways, address technical risks, and align outsourcing strategy with program goals.
Asecndia Pharmaceutical Solutions executives will host meetings at table #141 in the exhibition area to discuss formulation challenges, manufacturing readiness, development timelines, and commercialization planning across the clinical and commercial lifecycle. Direct access to executive leadership enables efficient, decision-oriented discussions aligned with sponsor priorities and development objectives.
Attendees at the Contract Pharma Conference are actively evaluating outsourcing partners capable of supporting their complex drug development programs while maintaining flexibility, speed, and technical execution. Ascendia Pharmaceutical Solutions provides integrated CDMO services aligned with these industry priorities by adhering to its “Fast; Flexible; First Time Right” mindset.
The company supports pharmaceutical and biotechnology programs through preformulation studies, formulation development, analytical method development and validation, clinical trial material manufacturing, scale-up activities, technology transfer, and commercial manufacturing preparation. This includes the ability to work with various dosage forms and routes of administration – oral solid dose, sterile injectables, ophthalmics – among others.
Ascendia Pharmaceutical Solutions also provides solutions for poorly soluble/bioavailable compounds and can address other complex drug delivery challenges that require specialized scientific and manufacturing expertise. This includes oral modified-release and long-acting injectable formulations that use our internal nanotechnology platforms.
Drug developers continue to face pressure to accelerate timelines while managing formulation complexity, regulatory expectations, and manufacturing scalability. Ascendia Pharmaceutical Solutions helps sponsors address these demands through integrated scientific and operational support designed to reduce development delays and improve manufacturing continuity.
Conference attendees will have opportunities to discuss bioavailability enhancement strategies, formulation optimization, process development, analytical support, manufacturing scalability, and CMC planning directly with Ascendia Pharmaceutical Solutions.
These discussions are particularly relevant for companies preparing for IND-enabling activities, clinical trial execution, late-stage scale-up, and commercial manufacturing transition.
The Contract Pharma Conference creates an environment for productive conversations between pharmaceutical sponsors and outsourcing partners managing increasingly complex development pipelines. Ascendia Pharmaceutical Solutions will engage with attendees on practical approaches for overcoming formulation barriers, managing manufacturing risk, and improving development efficiency.
The company’s integrated development and manufacturing capabilities support continuity across project phases while helping sponsors maintain focus on regulatory milestones, clinical timelines, and long-term commercialization objectives.
Pharmaceutical and biotechnology companies attending the 2026 Contract Pharma Conference are encouraged to connect with Ascendia Pharmaceutical Solutions during the event at the Hyatt Regency in New Brunswick, New Jersey.
Schedule a meeting in advance at Table 141 to secure time with Ascendia Pharmaceutical Solutions and discuss formulation development, analytical services, clinical manufacturing, technology transfer, and commercial manufacturing strategy specific to current and future programs.